Sharechat Logo

Powerco loses appeal against price controls on pipelines

Tuesday 12th August 2008

Text too small?
Powerco, the gas distributor half-owned by Australia's Babcock & Brown Infrastructure, lost an appeal against government-imposed price controls.

Powerco and Vector had challenged the Commerce Commission's recommendation on price controls that was adopted by the government. The commission in October 2005 ordered Powerco and Vector to reduce average pipeline prices by 9% and 9.5% respectively.

"Without price control, monopolies like Powerco can potentially overcharge consumers," said commission chair Paula Rebstock. "Reducing monopoly profits through lower prices is an obvious and significant benefit to gas consumers."

The decision comes a week after Babcock (BBI) said it may sell its 50% of Powerco after a review started in June to strengthen BBI's balance sheet and free up cash for investments.

BBI stock fell 2.4% to 85 Australian cents on the ASX today and has handed investors a loss of 40% in the past 12 months. Vector rose 1.4% to NZ$2.25 on the NZX.

Powerco is New Zealand's second-largest gas distributor, accounting for about 46% of the nation's gas connections. For Vector, the price controls only affected its Auckland gas network.

BBI, formerly Prime Infrastructure Networks, acquired Powerco four years ago from interests including local government organisations for NZ$680 million.


By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors